<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">34826619</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-0691</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</Title><ISOAbbreviation>Clin Microbiol Infect</ISOAbbreviation></Journal><ArticleTitle>Post-acute COVID-19 syndrome: a new tsunami requiring a universal case definition.</ArticleTitle><Pagination><StartPage>315</StartPage><EndPage>318</EndPage><MedlinePgn>315-318</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cmi.2021.11.015</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1198-743X(21)00661-3</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lled&#xf3;</LastName><ForeName>Gema M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Department of Autoimmune Diseases, University of Barcelona, Hospital Cl&#xed;nic, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sellares</LastName><ForeName>Jacobo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Hospital Cl&#xed;nic-Institut D'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brotons</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Sardenya Primary Health Care Centre, Biomedical Research Institute Sant Pau, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sans</LastName><ForeName>Mireia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Comte Borrell Health Care Centre, CAPSBE, Metges e-Salut, COMB, International University of Catalonia, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ant&#xf3;n</LastName><ForeName>Juana D&#xed;ez</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Molecular Virology Group, Department of Experimental and Health Sciences, University of Barcelona, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blanco</LastName><ForeName>Juli&#xe0;</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>IrsiCaixa AIDS Research Institute, Germans Trias I Pujol Research Institute (IGTP), Can Ruti Campus, Badalona, Catalonia, Spain; University of Vic (UVic-UCC), Vic, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bassat</LastName><ForeName>Quique</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>ISGlobal, Hospital Cl&#xed;nic, Universitat de Barcelona, Barcelona, Spain; Centro de Investiga&#xe7;&#xe3;o Em Sa&#xfa;de de Manhi&#xe7;a (CISM), Maputo, Mozambique; ICREA, Pg. Llu&#xed;s Companys 23, Barcelona, Spain; Paediatrics Department, Hospital Sant Joan de D&#xe9;u, Universitat de Barcelona, Esplugues, Barcelona, Spain; Consorcio de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (CIBERESP), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarukhan</LastName><ForeName>Adelaida</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Vic (UVic-UCC), Vic, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mir&#xf3;</LastName><ForeName>Jos&#xe9; M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Infectious Diseases Service, Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain. Electronic address: jmmiro@ub.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Sanjos&#xe9;</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>ISGlobal, Hospital Cl&#xed;nic, Universitat de Barcelona, Barcelona, Spain. Electronic address: desanjose.silvia@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Multidisciplinary Collaborative Group for the Scientific Monitoring of COVID-19 (GCMSC)</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Microbiol Infect</MedlineTA><NlmUniqueID>9516420</NlmUniqueID><ISSNLinking>1198-743X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coronavirus disease 2019</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post-acute coronavirus disease 2019 syndrome</Keyword><Keyword MajorTopicYN="N">Sequelae</Keyword><Keyword MajorTopicYN="N">Severe acute respiratory syndrome coronavirus 2</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>de Sanjos&#xe9;</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>NCI, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mir&#xf3;</LastName><ForeName>Josep M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nic - IDIBAPS, University of Barcelona, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bassat</LastName><ForeName>Quique</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>ICREA researcher at ISGlobal, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Campins</LastName><ForeName>Magda</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Vall d'Hebron, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Guerri</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hospital del Mar, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Brot&#xf3;ns</LastName><ForeName>Carles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>EAP Sardenya, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>D&#xed;ez</LastName><ForeName>Juana</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>CEXS, Universitat Pompeu Fabra, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Blanco</LastName><ForeName>Juli&#xe0;</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>IrsiCaixa-IGHTP, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sans</LastName><ForeName>Mireia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>CAP Borrell, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sarukhan</LastName><ForeName>Adelaida</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ISGlobal, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Plas&#xe8;ncia</LastName><ForeName>Antoni</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ISGlobal, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ant&#xf3;</LastName><ForeName>Josep M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>ISGlobal, Spain.</Affiliation></AffiliationInfo></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>26</Day><Hour>20</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34826619</ArticleId><ArticleId IdType="pmc">PMC8610558</ArticleId><ArticleId IdType="doi">10.1016/j.cmi.2021.11.015</ArticleId><ArticleId IdType="pii">S1198-743X(21)00661-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO Clinical management of severe acute respiratory infection when COVID-19 is suspected. http://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory- infection-when-novel-coronavirus-(ncov)-infection-is-suspected Available at:</Citation></Reference><Reference><Citation>Piroth L., Cottenet J., Mariet A.S., Bonniaud P., Blot M., Tubert-Bitter P., et al. Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study. Lancet Respir Med. 2021;9:251&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832247</ArticleId><ArticleId IdType="pubmed">33341155</ArticleId></ArticleIdList></Reference><Reference><Citation>https://apps.who.int/iris/bitstream/handle/10665/333857/WHO-2019-nCoV-Sci_Brief-Mortality-2020.1-spa.pdf</Citation></Reference><Reference><Citation>Dawood F.S., Iuliano A.D., Reed C., Meltzer M.I., Shay D.K., Cheng P.Y., et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis. 2012;12:687&#x2013;695.</Citation><ArticleIdList><ArticleId IdType="pubmed">22738893</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung M., Babik J.M. COVID-19 in immunocompromised hosts: what we know so far. Clin Infect Dis. 2021;72:340&#x2013;350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7337668</ArticleId><ArticleId IdType="pubmed">33501974</ArticleId></ArticleIdList></Reference><Reference><Citation>Squillace N., Ricci E., Colella E., Bonfanti P. HIV and SARS-CoV-2 Co-infection: what are the risks? Infect Drug Resist. 2021;14:3991&#x2013;4014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8487262</ArticleId><ArticleId IdType="pubmed">34611416</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagni F., Simon D., Tascilar K., Schoenau V., Sticherling M., Neurath M.F., et al. COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses. Lancet Rheumatol. 2021;3:e724&#x2013;e736.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8397302</ArticleId><ArticleId IdType="pubmed">34485930</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO New policy brief calls on decision-makers to support patients as 1 in 10 reports symptoms of &#x201c;long COVID&#x201d;. https://www.who.int/news-room/events/detail/2021/02/09/default-calendar Available at:</Citation></Reference><Reference><Citation>Subdirectorate general for surveillance and public health emergency response &#x2013; public health agency of Catalonia. 2020. https://dadescovid.cat/ (PHAC). Dades COVID [Internet]. Generalitat de Catalunya. Available at:</Citation></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet [Internet. 2021;397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>The prevalence of long COVID symptoms and COVID-19 complications&#x2014;office for National Statistics. https://www.ons.gov.uk/news/statementsandletters/theprevalenceoflongcovidsymptomsandcovid19complications [Internet]. Available at:</Citation></Reference><Reference><Citation>Petrie J.G., Cheng C., Malosh R.E., VanWormer J.J., Flannery B., Zimmerman R.K., et al. Illness severity and work productivity loss among working adults with medically attended acute respiratory illnesses: US Influenza Vaccine Effectiveness Network 2012&#x2013;2013. Clin Infect Dis. 2016;62:448&#x2013;455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4725387</ArticleId><ArticleId IdType="pubmed">26565004</ArticleId></ArticleIdList></Reference><Reference><Citation>Herridge M.S., Cheung A.M., Tansey C.M., Matte-Martyn A., Diaz-Granados N., Al-Saidi F., et al. Canadian Critical Care Trials Group. One-year outcomes in survivors of the acute respiratory distress syndrome. N&#xa0;Engl J Med. 2003;348:683&#x2013;693.</Citation><ArticleIdList><ArticleId IdType="pubmed">12594312</ArticleId></ArticleIdList></Reference><Reference><Citation>2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021 WHO. [Accessed 6 October 2021]</Citation></Reference><Reference><Citation>https://www.isglobal.org/es/gcmsc Available at:</Citation></Reference><Reference><Citation>The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China, 2020. China CDC Wkly. 2020. http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51 8:113e22. Available at:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8392929</ArticleId><ArticleId IdType="pubmed">34594836</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P., Cuapio A., et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11:16144. Res Sq [Preprint]. 2021 Mar 1:rs.3.rs-266574. Update in. PMID: 33688642; PMCID: PMC7941645.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., et al. Post-acute COVID-19 syndrome. Nat Med [Internet] 2021:1&#x2013;15. doi: 10.1038/s41591-021-01283-z. Available at: [Accessed 13 April 2021]</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>de Melo G.D., Lazarini F., Levallois S., Hautefort C., Michel V., Larrous F., et al. COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci Transl Med. 2021;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8158965</ArticleId><ArticleId IdType="pubmed">33941622</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C., Wang Z., Lorenzi J.C.C., Muecksch F., Finkin S., Tokuyama M., et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591:639&#x2013;644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Elrashdy F., Aljaddawi A.A., Redwan E.M., Uversky V.N. On the potential role of exosomes in the COVID-19 reinfection/reactivation opportunity. J&#xa0;Biomol Struct Dyn. 2020:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7441802</ArticleId><ArticleId IdType="pubmed">32643586</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin L.B., Weinstock L.B., Molderings G.J. COVID-19 hyperinflammation and post-COVID-19 illness may be rooted in mast cell activation syndrome. Int J Infect Dis. 2020;100:327&#x2013;332.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7529115</ArticleId><ArticleId IdType="pubmed">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson B.K., Guevara-Coto J., Yogendra R., Francisco E.B., Long E., Pise A., et al. Immune-based prediction of COVID-19 severity and chronicity decoded using machine learning. Front Immunol. 2021;12:700782.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8273732</ArticleId><ArticleId IdType="pubmed">34262570</ArticleId></ArticleIdList></Reference><Reference><Citation>Somani S.S., Richter F., Fuster V., De Freitas J.K., Naik N., Sigel K., Mount Sinai COVID Informatics Center Characterization of patients who return to hospital following discharge from hospitalization for COVID-19. J&#xa0;Gen Intern Med. 2020;35:2838&#x2013;2844.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7437962</ArticleId><ArticleId IdType="pubmed">32815060</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeo I., Baek S., Kim J., Elshakh H., Voronina A., Lou M.S., et al. Assessment of thirty-day readmission rate, timing, causes and predictors after hospitalization with COVID-19. J&#xa0;Intern Med. 2021;290:157&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013754</ArticleId><ArticleId IdType="pubmed">33452824</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;nster C., Busse R., Spoden M., Rombey T., Schillinger G., Hoffmann W., et al. 6-month mortality and readmissions of hospitalized COVID-19 patients: a nationwide cohort study of 8,679 patients in Germany. PLoS One. 2021;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8341502</ArticleId><ArticleId IdType="pubmed">34351975</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold D.T., Milne A., Samms E., Stadon L., Maskell N.A., Hamilton F.W. Symptoms after COVID-19 vaccination in patients with persistent symptoms after acute infection: a case series. Ann Intern Med. 2021;174:1334&#x2013;1336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8252827</ArticleId><ArticleId IdType="pubmed">34029484</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long COVID-mechanisms, risk factors, and management. BMJ. 2021;vol. 374:n1648. doi: 10.1136/bmj.n1648. Erratum in: BMJ. 2021 Aug 3;374:n1944. PMID: 34312178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien H., Tracey M.J., Ottewill C., O&#x2019;Brien M.E., Morgan R.K., Costello R.W., et al. An integrated multidisciplinary model of COVID-19 recovery care. Ir J Med Sci. 2021;190:461&#x2013;468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7475726</ArticleId><ArticleId IdType="pubmed">32894436</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease 2020 Health Financing Collaborator Network Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990&#x2013;2050. Lancet. 2021;398:1317&#x2013;1343.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8457757</ArticleId><ArticleId IdType="pubmed">34562388</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>